Skip to main content
. 2022 Oct 18;20:345. doi: 10.1186/s12957-022-02796-8

Table 4.

Prognostic factors of a 3-year survival and local recurrence by univariate analysis (overall cohort)

Variables N=211 Overall survival (%) P* Disease-free survival (%) P* Cumulative local recurrence (%) P*
Age (years) 0.707 0.809 0.410
 ≤65 132 88.1 79.9 7.4
 > 65 79 86.0 80.2 4.4
Sex 0.090 0.898 0.312
 Male 124 90.6 79.9 7.8
 Female 87 82.5 80.4 3.9
BMI (kg/m2) 0.364 0.255 0.822
 ≤25 169 86.2 78.4 6.6
 >25 42 92.1 86.9 5.4
ASA score 0.385 0.144 0.373
 1 1 100.0 100.0 0.0
 2 85 83.9 75.8 9.7
 3 125 89.5 85.5 4.3
CEA (ng/ml) 0.056 0.001 0.010
 ≤6.5 164 89.7 84.7 4.0
 > 6.5 47 78.6 63.5 15.5
CA199 (ng/ml) <0.001 0.015 0.124
 ≤27 182 90.7 82.4 5.4
 > 27 29 64.5 63.0 13.5
Surgical approach 0.671 0.776 0.797
 Open 49 86.9 77.7 4.8
 Laparoscopy 92 85.6 79.3 7.5
 Robot 70 89.9 82.7 6.0
Previous abdominal surgery 0.528 0.307 0.285
 Yes 45 90.2 85.5 9.6
 No 166 86.6 78.6 5.4
Smoking and drinking history 0.433 0.222 0.155
 Yes 66 90.1 74.5 4.6
 No 145 86.1 82.6 10.1
Family history of CRC 0.285 0.637 0.233
 Yes 21 95.0 85.2 0.0
 No 190 86.4 79.5 7.1
With comorbidities 0.264 0.906 0.775
 Yes 80 83.4 80.0 5.6
 No 131 89.7 80.1 6.8
Postoperative adjuvant chemotherapy <0.001 <0.001 0.220
 Yes 47 70.6 85.0 10.2
 No 164 92.1 62.9 5.4
Perioperative morbidity 0.963 0.758 0.740
 Yes 45 87.8 77.8 5.4
 No 166 87.2 80.6 6.6
Tumor location 0.821 0.542 0.511
 TC&SF 50 89.2 85.6 4.4
 UDC 74 85.6 76.8 4.8
 LDC 87 87.7 79.6 8.7
With adenomatous polyps 0.009 0.067 0.137
 Yes 56 98.0 88.6 1.8
 No 155 83.6 77.0 8.1
Neoplasm diameter (cm) 0.395 0.816 0.089
 ≤5 136 85.8 80.7 4.2
 >5 75 89.9 79.0 10.2
Tumor differentiation 0.022 0.002 0.089
 Well 21 100.0 89.7 0.0
 Moderate 159 88.5 83.4 5.5
 Poor 20 74.4 59.2 13.8
 Mucinous 11 70.0 50.5 22.2
pTNM stage <0.001 <0.001 0.030
 I 34 96.6 90.1 0.0
 II 91 95.3 89.5 3.6
 III 86 75.9 66.4 11.9
pT stage 0.067 0.148 0.434
 T1 22 100.0 95.0 0.0
 T2 13 100.0 91.7 0.0
 T3 21 95.2 85.4 5.0
 T4a 155 83.5 76.4 7.9
pN stage <0.001 <0.001 0.007
 N0 125 95.7 89.6 2.7
 N1 58 87.5 74.9 9.1
 N2 28 52.0 48.9 19.4
Number of lymph nodes detected 0.395 0.856 0.306
 ≤15 137 85.8 79.8 5.0
 >15 74 89.9 80.4 8.8
With lymphovascular invasion <0.001 0.001 0.059
 Yes 35 69.9 59.8 14.8
 No 176 90.8 83.9 4.9
With extranodal tumor deposits 0.004 <0.001 0.331
 Yes 33 72.5 57.3 10.9
 No 178 90.3 84.5 5.6
With perineural invasion 0.001 <0.001 <0.001
 Yes 75 77.1 65.9 15.9
 No 136 92.8 87.7 1.6

Abbreviation: BMI Body mass index, ASA American Society of Anesthesiology, CRC Colorectal cancer, TC The distal 1/3 of the transverse colon, SF Splenic flexure, UDC Upper segment of descending colon, LDC Lower segment of the descending colon, pTNM Pathological tumor-node-metastasis

*The 3-year overall and disease-free survival rates and cumulative local recurrence were calculated by using the Kaplan–Meier method